Monrovia — Findings from three studies conducted by the Partnership for Research on Ebola Virus in Liberia (PREVAIL) were described Tuesday evening at a major scientific conference in the United States. The presentations occurred at a Special Session on Ebola during the 2016 Annual Conference on Retroviruses and Opportunistic Infections (CROI) being held in Boston, Massachusetts, February 22-25.
PREVAIL is a clinical research collaboration established in the fall of 2014 by Liberia's Ministry of Health and the U.S. Department of Health and Human Services. In February 2015, the partnership launched an Ebola vaccine trial in Liberia as their first study, PREVAIL I.
...